Jason Kelly, Ginkgo Bioworks CEO

Gink­go joins Es­per­ovax to at­tempt RNA can­cer treat­ment — in a pill

Gink­go Bioworks and Es­per­ovax are col­lab­o­rat­ing on mak­ing an RNA pill to treat col­orec­tal can­cers, the duo an­nounced Thurs­day.

The sci­ence is still in ear­ly …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.